Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,668
Late Onset Alzheimer's Disease
for
Alzheimer Disease
Location: Raleigh NC, Pittsburgh PA, New York NY, Bloomington IN,
Sponsor: Columbia University
Sex: All
Age: 55+
Code: NCT05010603
Recruiting
Restoration of Normative Postural Control
for
Lower Limb Amputation Below Knee (Injury)
Location: Raleigh NC
Sponsor: North Carolina State University
Sex: All
Age: 18 - 70+
Code: NCT06452186
Recruiting
R21: An Easy-to-use, iNtelligent, Affordable LinEr (ENABLE) System for Socket Fit Assessment
for
Lower Limb Amputation Below Knee (Injury)
Location: Raleigh NC
Sponsor: North Carolina State University
Sex: All
Age: 18 - 70+
Code: NCT05425810
Recruiting
ELEVATE-HFpEF Clinical Study
for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Durham NC, Falls Church VA, Charleston WV,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Sex: All
Age: 40+
Code: NCT06678841
Recruiting
Comparing Intact and Residual Amputated Muscle
for
Amputation
Location: Raleigh NC
Sponsor: North Carolina State University
Sex: All
Age: 18 - 64
Code: NCT06182202
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Improving Balance and Energetics of Walking Using a Hip Exoskeleton
for
Stroke
Location: Raleigh NC
Sponsor: North Carolina State University
Sex: All
Age: 18 - 64
Code: NCT05447884
Recruiting
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for
Chronic Idiopathic Constipation (CIC)
Location: Cary NC, Raleigh NC, Rocky Mount NC, High Point NC,
Sponsor: Ardelyx
Sex: All
Age: 18 - 70+
Code: NCT07382167
Phase 3, Recruiting
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
for
Dravet Syndrome
Location: Durham NC, Philadelphia PA, Ann Arbor MI, Memphis TN,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 2 - 12
Code: NCT07531745
Phase 1, Phase 2, Recruiting
Genepro Generation 3 Protein Bioavailability Compared to Whey Protein
for
Absorption; Disorder, Protein, Protein Malabsorption,
Location: Cary NC
Sponsor: Musclegen Research, Inc.
Sex: All
Age: 25 - 70+
Code: NCT04615858
Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Raleigh NC, Charlotte NC, Greenville SC, Vienna VA,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Cary NC, Wake Forest NC, West Columbia SC,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Cary NC, Wake Forest NC, West Columbia SC,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase 3, Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: Cary NC, Charlotte NC, Greenville SC, Rockville MD,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 12 - 17
Code: NCT07133308
Phase 3, Recruiting
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Cary NC, Baltimore MD, Snellville GA, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07573176
Phase 3, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Raleigh NC, Wake Forest NC, Columbia SC,
Sponsor: Amgen
Sex: All
Age: 50+
Code: NCT07614776
Phase 3, Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin